论文部分内容阅读
据资料统计,2008年我国感冒药的零售市场销售额高达92亿元。有关人士分析,75%的人一年之内至少会患一次感冒,如果我国每年有10亿人次患感冒,人均购买15元～20元的药品,感冒药的市场容量至少有150亿元～200亿元。目前我国有1000多家药厂在生产大同小异的感冒药,而外资药企更是强势进攻,占据了中国感冒药市场60%以上的份额。这就是中国的“感冒经济”。另有调查显示,参与调查的两万人中,90%的人每年会患1～5次感冒,53%的人每次感冒要花费100元～200元,近70%的人表示“治感冒很贵”。有人粗略计算了一下,若以每人每年患感冒两次,每次治疗花费100元计算,“感冒经济”每年产生的消费竟高达3000亿元。
According to statistics, in 2008, China’s retail sales of cold medicine reached as high as 9.2 billion yuan. Analysis of relevant persons, 75% of people within a year at least have a cold, if China has 1 billion people each year suffering from a cold, per capita purchase of 15 yuan to 20 yuan of drugs, cold medicine market capacity of at least 15 billion yuan 200 100 million yuan. At present, there are more than 1,000 pharmaceutical companies producing similar cold medicines in China, while foreign pharmaceutical companies are even more aggressive. They account for more than 60% of the Chinese cold medicine market. This is China’s “cold economy”. Another survey shows that 90% of the 20,000 people surveyed suffer from 1 to 5 cold episodes each year, while 53% of people have to spend 100 yuan to 200 yuan for each cold. Nearly 70% of the people said that “ Cold is very expensive. ” Some people make a rough calculation. If you catch a cold twice per person per year and spend 100 yuan per treatment, the annual cost of “cold economy” is as high as 300 billion yuan.